Dividend income
2.17 $
Earnings per share
-26.61 $
Price/earnings (P/E)
-
Capitalization
19.7 billion $
Sector
Healthcare
Shares outstanding
158.3 million
Capitalization
19.7 billion $
Price/earnings (P/E)
-
Earnings per share
-26.61 $
Dividend rate
-
Dividend income
2.17 $
Illumina, Inc. - developer and manufacturer of genetic analysis systems. The company produces products and services for sequencing, genotyping, gene expression studies. The companys products are used by genomic research centers, pharmaceutical companies, research institutes, and biotechnology companies. Manufactures a line of products and services for sequencing, genotyping and studying gene expression. Founded in 1998.